Microorganisms (Apr 2024)

Characterization of <i>Escherichia coli</i> Strains for Novel Production of <i>Plasmodium ovale</i> Lactate Dehydrogenase

  • Jae-Won Choi,
  • Sang-Oh Ha,
  • Yeon-Jun Kim,
  • Jun-Seop Shin,
  • Min-Ji Choi,
  • Si-Eun Yu,
  • Junghun Han,
  • Eun-Ji Park,
  • Kyoung Sik Park,
  • Jung Hoon Kang

DOI
https://doi.org/10.3390/microorganisms12050876
Journal volume & issue
Vol. 12, no. 5
p. 876

Abstract

Read online

Malaria is one of the most prevalent diseases worldwide with high incidence and mortality. Among the five species that can infect humans, Plasmodium ovale morphologically resembles Plasmodium vivax, resulting in misidentification and confusion in diagnosis, and is responsible for malarial disease relapse due to the formation of hypnozoites. P. ovale receives relatively less attention compared to other major parasites, such as P. falciparum and P. vivax, primarily due to its lower pathogenicity, mortality rates, and prevalence rates. To efficiently produce lactate dehydrogenase (LDH), a major target for diagnosing malaria, this study used three Escherichia coli strains, BL21(DE3), BL21(DE3)pLysS, and Rosetta(DE3), commonly used for recombinant protein production. These strains were characterized to select the optimal strain for P. ovale LDH (PoLDH) production. Gene cloning for recombinant PoLDH production and transformation of the three strains for protein expression were performed. The optimal PoLDH overexpression and washing buffer conditions in nickel-based affinity chromatography were established to ensure high-purity PoLDH. The yields of PoLDH expressed by the three strains were as follows: BL21(DE3), 7.6 mg/L; BL21(DE3)pLysS, 7.4 mg/L; and Rosetta(DE3), 9.5 mg/L. These findings are expected to be highly useful for PoLDH-specific diagnosis and development of antimalarial therapeutics.

Keywords